Overview

MRI in Predicting Early Response to Chemotherapy in Patients With Locally Advanced Breast Cancer

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Diagnostic procedures such as MRI scans may help predict early response to treatment in patients with breast cancer undergoing chemotherapy. PURPOSE: This phase II trial is studying MRI in predicting early response to chemotherapy in patients with locally advanced breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Cancer Clinical Trials Unit, Scotland